BIOMAT Database Logo BIOMAT Database Logo

Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha. 2000

P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Laboratoire de Virologie, Centre Hospitalier et Universitaire de Bordeaux, France.

We quantified hepatitis C virus (HCV) RNA at different times in plasma and peripheral blood mononuclear cells (PBMC) in 51 patients with chronic hepatitis C undergoing interferon-alpha2a (IFN-alpha2a) therapy. HCV RNA loads in plasma correlated with those in PBMC before and during the treatment (P<0.001). After treatment, a sustained response was observed in 19 patients (SR), a response followed by relapse in 9 (RR), and non response in 23 (NR). By univariate analysis PBMC HCV RNA load before treatment was lower in SR than in RR and NR (P = 0.003). In the 9 RR, HCV RNA disappeared in PBMC before or at the same time as in plasma and again became detectable in plasma and PBMC simultaneously or earlier in plasma. These results indicate that quantitation of HCV RNA in PBMC is not a useful parameter for the follow-up of treated patients.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic

Related Publications

P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon.
February 1995, Journal of medical virology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha.
November 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Hepatitis C virus replication in liver and peripheral blood mononuclear cells of interferon-alpha-treated and untreated patients with chronic hepatitis C.
January 1994, Scandinavian journal of gastroenterology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.
March 2013, Postepy higieny i medycyny doswiadczalnej (Online),
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Quantitation of hepatitis C virus in liver and peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection.
April 1998, Journal of medical virology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after alpha-interferon therapy.
July 1999, The American journal of gastroenterology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Electron microscopic studies of peripheral blood mononuclear cells in chronic type C hepatitis treated with interferon-alpha.
January 1995, Ultrastructural pathology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.
October 1998, Hepatology (Baltimore, Md.),
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
November 2000, Journal of medical virology,
P Trimoulet, and P H Bernard, and V de Ledinghen, and B Oui, and G Chene, and M F Saint-Marc Girardin, and S Dantin, and P Couzigou, and H Fleury
Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
July 1995, Journal of medical virology,
Copied contents to your clipboard!